HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice.

Abstract
The effect of morroniside on lipid metabolism and the inflammatory response in the liver of type 2 diabetes model mice was investigated in this study. Male C57BLKS/J db/db mice were divided into the three groups: control (vehicle), morroniside 20, or 100 mg/kg body weight-treated mice. The elevated serum triglyceride and alanine aminotransferase levels as well as hepatic glucose and lipids contents in db/db mice were significantly decreased by the 8-week oral administration of morroniside in a dose-dependent manner. The generations of hepatic thiobarbituric acid-reactive substances and reactive oxygen species induced by hyperglycemia and dyslipidemia were also significantly decreased by the administration of morroniside. In addition, the barometer of an antioxidative state, the oxidized to reduced glutathione ratio, in the liver of db/db mice was markedly increased by morroniside treatment. From protein analysis, the elevated expressions of nuclear factor-kappaBp65, cyclooxygenase-2, inducible nitric oxide synthase, and sterol regulatory element binding proteins (SREBP-1 and SREBP-2) were down-regulated in the liver of db/db mice. On the other hand, the administration of morroniside significantly increased hepatic peroxisome proliferator activated receptor alpha expression. These results suggest that morroniside would act as a regulator of hepatic inflammatory reactions and lipid metabolism in db/db mice.
AuthorsChan Hum Park, Noriko Yamabe, Jeong Sook Noh, Ki Sung Kang, Takashi Tanaka, Takako Yokozawa
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 32 Issue 10 Pg. 1734-40 (Oct 2009) ISSN: 1347-5215 [Electronic] Japan
PMID19801836 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • Glycosides
  • Hypolipidemic Agents
  • Inflammation Mediators
  • PPAR alpha
  • Plant Extracts
  • Reactive Oxygen Species
  • Srebf1 protein, mouse
  • Srebf2 protein, mouse
  • Sterol Regulatory Element Binding Protein 1
  • Sterol Regulatory Element Binding Protein 2
  • Thiobarbiturates
  • Triglycerides
  • morroniside
  • Alanine Transaminase
  • Glutathione
  • Glucose
  • thiobarbituric acid
Topics
  • Alanine Transaminase (blood)
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Antioxidants (pharmacology, therapeutic use)
  • Cornus (chemistry)
  • Diabetes Mellitus, Experimental (drug therapy, metabolism)
  • Down-Regulation
  • Fruit
  • Gene Expression
  • Glucose (metabolism)
  • Glutathione (metabolism)
  • Glycosides (pharmacology, therapeutic use)
  • Hypolipidemic Agents (pharmacology, therapeutic use)
  • Inflammation Mediators (blood)
  • Lipid Metabolism (drug effects)
  • Liver (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • PPAR alpha (metabolism)
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Reactive Oxygen Species (metabolism)
  • Sterol Regulatory Element Binding Protein 1 (metabolism)
  • Sterol Regulatory Element Binding Protein 2 (metabolism)
  • Thiobarbiturates (metabolism)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: